» Articles » PMID: 29414259

CD8 T Cell Exhaustion in Chronic Infection and Cancer: Opportunities for Interventions

Overview
Journal Annu Rev Med
Publisher Annual Reviews
Specialty General Medicine
Date 2018 Feb 8
PMID 29414259
Citations 333
Authors
Affiliations
Soon will be listed here.
Abstract

Antigen-specific CD8 T cells are central to the control of chronic infections and cancer, but persistent antigen stimulation results in T cell exhaustion. Exhausted CD8 T cells have decreased effector function and proliferative capacity, partly caused by overexpression of inhibitory receptors such as programmed cell death (PD)-1. Blockade of the PD-1 pathway has opened a new therapeutic avenue for reinvigorating T cell responses, with positive outcomes especially for patients with cancer. Other strategies to restore function in exhausted CD8 T cells are currently under evaluation-many in combination with PD-1-targeted therapy. Exhausted CD8 T cells comprise heterogeneous cell populations with unique differentiation and functional states. A subset of stem cell-like PD-1 CD8 T cells responsible for the proliferative burst after PD-1 therapy has been recently described. A greater understanding of T cell exhaustion is imperative to establish rational immunotherapeutic interventions.

Citing Articles

Targeting Immune Checkpoint Inhibitors for Non-Small-Cell Lung Cancer: Beyond PD-1/PD-L1 Monoclonal Antibodies.

Roussot N, Kaderbhai C, Ghiringhelli F Cancers (Basel). 2025; 17(5).

PMID: 40075753 PMC: 11898530. DOI: 10.3390/cancers17050906.


Functional memory T cells are derived from exhausted clones and expanded by checkpoint blockade.

Raposo C, Yan P, Chen A, Majidi S, Hiam-Galvez K, Satpathy A bioRxiv. 2025; .

PMID: 39990338 PMC: 11844384. DOI: 10.1101/2025.02.10.637523.


Stem-like memory and precursors of exhausted T cells share a common progenitor defined by ID3 expression.

Gago da Graca C, Sheikh A, Newman D, Wen L, Li S, Shen J Sci Immunol. 2025; 10(103):eadn1945.

PMID: 39888981 PMC: 7617396. DOI: 10.1126/sciimmunol.adn1945.


Comprehensive analysis of ESCRT transcriptome-associated signatures and identification of the regulatory role of LMO7-AS1 in osteosarcoma.

Zhao S, Tian D, Huang F, Wang L, Cheng J, He Z Cancer Cell Int. 2025; 25(1):29.

PMID: 39885569 PMC: 11783933. DOI: 10.1186/s12935-025-03659-4.


Targeting SRSF1 improves cancer immunotherapy by dually acting on CD8T and tumor cells.

Zhu G, Tang Z, Chu T, Wang B, Chen S, Tao C Signal Transduct Target Ther. 2025; 10(1):25.

PMID: 39837814 PMC: 11751439. DOI: 10.1038/s41392-024-02118-2.